SALT LAKE CITY — Denali Therapeutics is advancing the fight against neurodegenerative diseases thanks to pioneering work in methods to carry medicines across the blood-brain barrier, a critical step ...

A Denali Therapeutics drug for the rare enzyme deficiency Hunter syndrome is still in pivotal testing, but the company has guidance from the FDA on a pathway to get this therapy to the market sooner.

The view of the backcountry from Camp Denali, a wilderness lodge that's been in operation since before Alaska became a state. Photo Credit: Murray Cohen A single, 92-mile stretch of road is the only ...